Optimizing Aspirin and Clopidogrel Therapy (BOchum CLopidogrel and Aspirin Plan)
Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
Dual antiplatelet therapy with acetylsalicylic acid (ASA, aspirin) and clopidogrel is of
great importance for treatment following coronary stenting. Unfortunately the variable
platelet inhibitory effectiveness compromises the antithrombotic benefit of dual antiplatelet
therapy. The aim of this prospective single centre study was to reduce the low response
incidence of dual antiplatelet therapy with ASA and clopidogrel based on a standardized
therapy algorithm.